Views

CrossRef citations to date

Altmetric

Diabetes

Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes

Louis S. MatzaPatient-Centered Research, Evidera, Bethesda, MD, USA; Correspondence[email protected]

Kristina S. BoyeEli Lilly and Company, Indianapolis, IN, USA

Brooke M. CurriePatient-Centered Research, Evidera, Bethesda, MD, USA;

Rosirene PaczkowskiEli Lilly and Company, Indianapolis, IN, USA

Laura F. LandoEli Lilly and Company, Indianapolis, IN, USA

Reema ModyEli Lilly and Company, Indianapolis, IN, USA

Jessica JordanPatient-Centered Research, Evidera, Bethesda, MD, USA;

show all

Figures & data

Figure 1. Data disposition flowchart.Note: Thicker lines bordering the boxes in this figure indicate groups or subgroups used in the analyses.

Table 1. Demographic and clinical characteristics.

Download CSV Display Table

Table 2. ANCOVAs comparing patient perceptions of the dulaglutide and liraglutide devices on the DID-EQTable Footnote^a (N = 404).

Download CSV Display Table

Figure 2. Percentages of respondents who selected each response option of the DID-PQCitation¹ global items (N = 58).

Figure 2. Percentages of respondents who selected each response option of the DID-PQCitation1 global items (N = 58).

Table 3. Frequencies and percentages of respondents who selected each response option of the DID-PQ^a (N = 58).

Download CSV Display Table

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes

Table 1. Demographic and clinical characteristics.

Table 2. ANCOVAs comparing patient perceptions of the dulaglutide and liraglutide devices on the DID-EQTable Footnote^a (N = 404).

Table 3. Frequencies and percentages of respondents who selected each response option of the DID-PQ^a (N = 58).

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes

Figures & data

Table 1. Demographic and clinical characteristics.

Table 2. ANCOVAs comparing patient perceptions of the dulaglutide and liraglutide devices on the DID-EQTable Footnotea (N = 404).

Table 3. Frequencies and percentages of respondents who selected each response option of the DID-PQa (N = 58).

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 2. ANCOVAs comparing patient perceptions of the dulaglutide and liraglutide devices on the DID-EQTable Footnote^a (N = 404).

Table 3. Frequencies and percentages of respondents who selected each response option of the DID-PQ^a (N = 58).